Pediatric rheumatology

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome

LupusPublished Prospective cohort study

Authors' conclusion

At 2 years of follow-up, all pSLE patients had a lower ANA titer and 26% became negative; however, all pSS patients remained both ANA and ENA positive.

Study context

Population
Children with pediatric systemic lupus erythematosus (pSLE) and pediatric Sjögren's syndrome (pSS); autoantibody testing every 3–4 months for 2 years from disease onset
Participants
21 vs 22
Exposure
pSLE vs pSS
  • pSLEn = 21
  • pSSn = 22
Outcome
Trend of autoantibody titers
Follow-up
2 years
Methodological detailslongitudinal, 2-year follow-up
  • Longitudinal
  • 2-year follow-up

Main finding

As reported in the abstract

ANA status at 2 years (pSLE)

Still ANA positive at 2 years

11

73%

Became ANA negative

4

26%

pSS: all remained ANA positive at 2 years, with significantly lower titers

100%

Observational data: associations, not effects.

Further findings

ANA pattern at diagnosis in pSLE

Homogeneous pattern
12 (80%)
Speckled pattern (remained ANA positive, same pattern)
3 (20%)
Homogeneous converted to speckled
2
Homogeneous became ANA negative
4

Interferon score, ANA negative vs ANA positive pSLE

ANA negative pSLE patients had lower interferon score than ANA positive

Anti-dsDNA titers in pSLE

Declined equally in the two groups

ENA in pSS

Anti-La positive at onset
14 (66%)
All ANA and anti-Ro positive at disease onset
Anti-Ro and anti-La titers remained stable during follow-up

Original publication

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome. Lupus. Published 4 November 2024. doi:10.1177/09612033241298729

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.